Latest News - Acne

Tuesday, October 30, 2018

Ortho Dermatologics' Altreno Now Available in the US

Ortho Dermatologics launched Altreno (tretinoin) Lotion, 0.05% for the topical treatment of acne vulgaris in patients 9 years of age and older. Altreno Lotion is the first and only tretinoin available…

Read the full story

Tuesday, October 23, 2018

Almirall, LLC is the New Name of Aqua

Almirall, LLC is the new name of Aqua Pharmaceuticals. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, wit…

Read the full story

Thursday, October 18, 2018

Almirall’s Seysara Set to Shake Up US Acne Market

The US Food and Drug Administration’s approval of Almirall’s Seysara (sarecycline) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients age…

Read the full story

Thursday, October 11, 2018

Pre-conditioning Added to Sebacia Microparticles Enhances Outcomes

Using pre-conditioning in conjunction with Sebacia Microparticles for treatment of acne leads to enhanced outcomes, new data suggest. In fact, results from a real-world, pre-conditioning registry tria…

Read the full story

Thursday, October 11, 2018

Study: Positive Safety and Tolerability Results for Ortho Dermatologics' Altreno for Acne

Ortho Dermatologics shared results of two identical Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel group studies examining the efficacy and safety of Altreno (tretinoin) …

Read the full story

Wednesday, October 03, 2018

Acne Stigma Linked to Lower Overall Q of L

Acne patients perceived social stigma negatively affects their quality of life, according to a new study from the University of Limerick. In the survey of 271 people with acne, those whose negative…

Read the full story

Tuesday, October 02, 2018

Seysara: Oral Antibiotic is First Approved for Dermatology in 40 Years

Seysara (sarecycline), a new, first in class tetracycline-derived oral antibiotic, is now approved for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients…

Read the full story

Tuesday, October 02, 2018

Is Teen Acne a Sign of Future Financial Success?

The love of books, the need for glasses and high intelligence are traits found among the top earners in many fields across the country, and now, a Ball State University researcher suggests that teen a…

Read the full story

Friday, September 28, 2018

Bellus Medical Now Part of Crown Laboratories

Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusi…

Read the full story

Monday, September 24, 2018

Nestle to Explore Strategic Options for Skin Health Division

...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic…

Read the full story

Tuesday, September 18, 2018

FDA Clears Sebacia Microparticles for Laser-Based Acne Treatment

Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Se…

Read the full story

Wednesday, September 12, 2018

Foamix: Positive Topline Phase 3 Results for Topical Minocycline Foam

Foamix Pharmaceuticals’ FMX101 topical minocycline foam for the treatment of moderate-to-severe acne has met primary endpoints of its third Phase 3 clinical trial. Foamix shared topline resul…

Read the full story

Friday, August 24, 2018

FDA Nod for Ortho Derm’s Acne Lotion Altreno

The U.S. Food and Drug Administration (FDA) approved the New Drug Application for Ortho Dermatologic’s Altreno (tretinoin 0.05%) lotion, indicated for the topical treatment of acne vulgaris in p…

Read the full story

Friday, August 03, 2018

Almirall to Acquire Allergan’s US Medical Dermatology Unit

Almirall is acquiring a portfolio of five products from Allergan’s Medical Dermatology unit in the United States, conditional to the clearance by the relevant authorities. The portfolio includes…

Read the full story

Thursday, July 26, 2018

Link Between Diet and Skin Disease Takes Center Stage at Summer AAD

Dermatologists must help patients determine if there are any foods that may cause their skin condition to flare and provide evidence-based recommendations about next steps. “People looki…

Read the full story
Load More